Stelexis Therapeutics
About:
Stelexis Therapeutics is a company utilizes pre-cancerous stem cells to discover and develop transformative therapies.
Website: https://www.stelexis.com/
Top Investors: Deerfield, Deerfield Capital Management
Description:
Stelexis Therapeutics is to become the cancer therapeutics company, through the discovery and development of novel drugs, utilizing its proprietary platform to selectively target pre-cancerous stem cells. The company will initially focus on therapeutics for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
$43M
New York, New York, United States
2017-01-01
Amit Verma, Derrick Rossi, Evripidis Gavathiotis, Roman Perez-Soler, Ulrich Steidl
1-10
2019-01-08
Private
© 2025 bioDAO.ai